马塞利尼南准SLC7A11,通过STAT6/PPAR-γ/KLF4信号传导诱导铁和调节巨分极
Dianyu Sun1, Xingzhe Liu2, Chuwen Mao2
1Department of Gastroenterology, Yanbian University Hospital, Yanji, China.
Bioorganic chemistry
|December 28, 2025
概括
天然化合物马赛林南通过诱导铁亡来重编程肝癌中的瘤相关巨细胞 (TAMs). 这种机制针对SLC7A11,将TAM转移到抗瘤状态,并抑制肝细胞癌 (HCC) 的生长.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 具有M2表型的瘤相关巨细胞 (TAM) 促进肝细胞癌 (HCC) 的发展和免疫逃避.
- 重编程TAM为HCC提供了一个潜在的治疗策略.
研究的目的:
- 研究天然产品 macelignan (mace) 影响 HCC.中 TAM 两极化的机制.
- 为了探索铁化在马氏介导的TAM重编程中的作用.
主要方法:
- 在HCC受条件介质中进行巨细胞极化测定.
- 对铁灭菌标记物的评估 (谷氨,脂质过氧化,SLC7A11,GPX4).
- 计算建模和细胞热转移分析以确定分子相互作用.
- 在体内异种移植模型评估抗瘤疗效和毒性.
主要成果:
- 马塞利尼南通过耗尽谷和增加脂质过氧化来诱导HCC条件下的巨细胞中的铁.
- 阻断铁亡阻止了M2表型的恢复,证实了该机制.
- 马塞利尼南与SLC7A11直接相互作用,损害了STAT6/PPAR-γ/KLF4通路,并减少了CCL2的产生.
- 马塞利南将TAM重编程为抗瘤表型,抑制HCC细胞生长,迁移和上皮-介质细胞过渡.
- 在体内,马塞抑制了瘤生长和转移,没有系统性毒性.
结论:
- 马塞利尼南通过一种依赖铁灭的机制对TAM进行重新编程,以SLC7A11.11为目标.
- 这种重编程将TAM转移到抗瘤表型,抑制HCC的进展.
- 梅赛利南代表了一种有前途的天然产品,用于调节HCC的瘤免疫微环境.
相关概念视频
Cell Specific Gene Expression
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Regulation of Nuclear Protein Sorting
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
Calmodulin-dependent Signaling
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...

